Literature DB >> 8554307

Clinical pharmacokinetics of oral cephalosporins.

K Stoeckel1, W L Hayton, D J Edwards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8554307     DOI： 10.1159/000430073

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN： 0066-4758


× No keyword cloud information.
  9 in total

Review 1.  Cefuroxime axetil: an updated review of its use in the management of bacterial infections.

Authors:  L J Scott; D Ormrod; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Novel carbapenem antibiotics for parenteral and oral applications: in vitro and in vivo activities of 2-aryl carbapenems and their pharmacokinetics in laboratory animals.

Authors:  Koichi Fujimoto; Koji Takemoto; Kazuo Hatano; Toru Nakai; Shigeyuki Terashita; Masahiro Matsumoto; Yoshiro Eriguchi; Ken Eguchi; Takeshi Shimizudani; Kimihiko Sato; Katsunori Kanazawa; Makoto Sunagawa; Yutaka Ueda
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

Review 3.  Ontogeny of drug elimination by the human kidney.

Authors:  Nancy Chen; Katarina Aleksa; Cindy Woodland; Michael Rieder; Gideon Koren
Journal:  Pediatr Nephrol       Date:  2005-12-06       Impact factor: 3.714

Review 4.  Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.

Authors:  B Fulton; C M Perry
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

5.  Influence of maturation and growth on cefetamet pivoxil pharmacokinetics: rational dosing for infants.

Authors:  W L Hayton; J Kneer; R de Groot; K Stoeckel
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

6.  Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state.

Authors:  K Stoeckel; M Harell; M Dan
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

7.  Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infections.

Authors:  M Cazzola; M G Matera; C F Donner
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

8.  Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailability.

Authors:  K Stoeckel; W Hofheinz; J P Laneury; P Duchene; S Shedlofsky; R A Blouin
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

9.  New semiphysiological absorption model to assess the pharmacodynamic profile of cefuroxime axetil using nonparametric and parametric population pharmacokinetics.

Authors:  J B Bulitta; C B Landersdorfer; M Kinzig; U Holzgrabe; F Sorgel
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.